spacer gif spacer gif spacer gif spacer gif ARCHIVE ANNOUNCEMENT! spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online December 21, 2007
doi: 10.1242/10.1242/dev.001883


Development 135, 193-205 (2008)
Published by The Company of Biologists 2008


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laugwitz, K.-L.
Right arrow Articles by Chien, K. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laugwitz, K.-L.
Right arrow Articles by Chien, K. R.

Review

Islet1 cardiovascular progenitors: a single source for heart lineages?

Karl-Ludwig Laugwitz1,2,*, Alessandra Moretti1,2,*, Leslie Caron1, Atsushi Nakano1 and Kenneth R. Chien1,3,*

1 Massachusetts General Hospital - Cardiovascular Research Center, Charles River Plaza/CPZN 3208, 185 Cambridge Street, Boston, MA 02114, USA.
2 Klinikum rechts der Isar und Deutsches Herzzentrum - Technische Universität München, I. Medizinische Klinik - Molekulare Kardiologie, Ismaninger Strasse 22, 81675 München, Germany.
3 Department of Stem Cell and Regenerative Biology, Harvard University and the Harvard Stem Cell Institute, Cambridge, MA 02138, USA.

* Authors for correspondence (e-mails: klaugwitz{at}med1.med.tum.de, amoretti{at}med1.med.tum.de, kchien{at}partners.org)

SUMMARY

The creation of regenerative stem cell therapies for heart disease requires that we understand the molecular mechanisms that govern the fates and differentiation of the diverse muscle and non-muscle cell lineages of the heart. Recently, different cardiac cell types have been reported to arise from a common, multipotent Islet1 (Isl1)-positive progenitor, suggesting that a clonal model of heart lineage diversification might occur that is analogous to hematopoiesis. The ability to isolate, renew and differentiate Isl1+ precursors from postnatal and embryonic hearts and from embryonic stem cells provides a powerful cell-based system for characterizing the signaling pathways that control cardiovascular progenitor formation, renewal, lineage specification and conversion to specific differentiated progeny.




This article has been cited by other articles:


Home page
CirculationHome page
G. Narazaki, H. Uosaki, M. Teranishi, K. Okita, B. Kim, S. Matsuoka, S. Yamanaka, and J. K. Yamashita
Directed and Systematic Differentiation of Cardiovascular Cells From Mouse Induced Pluripotent Stem Cells
Circulation, July 29, 2008; 118(5): 498 - 506.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
N. Smart and P. R. Riley
The Stem Cell Movement
Circ. Res., May 23, 2008; 102(10): 1155 - 1168.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
I. S. Jovin and F. J. Giordano
Differentiation by association: is a cell's fate determined by the company it keeps?
Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1503 - H1504.
[Full Text] [PDF]


Home page
DevelopmentHome page
E. D. Cohen, Y. Tian, and E. E. Morrisey
Wnt signaling: an essential regulator of cardiovascular differentiation, morphogenesis and progenitor self-renewal
Development, March 1, 2008; 135(5): 789 - 798.
[Abstract] [Full Text] [PDF]




© The Company of Biologists Ltd 2008